Company Filing History:
Years Active: 2016-2018
Title: **Innovative Contributions of Kristy Haas in Cancer Treatment**
Introduction
Kristy Haas is a notable inventor based in Brighton, MA, recognized for her significant contributions in the field of cancer treatment. With a focus on developing combination therapies, she has successfully patented innovative solutions that aim to improve patient outcomes.
Latest Patents
Kristy Haas holds two patents that reflect her dedication to advancing medical treatment options. Her latest patents include:
1. A combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer.
2. A combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer.
These inventions showcase her expertise in the development of targeted therapies for cancer patients.
Career Highlights
Currently, Kristy is affiliated with Novartis AG, a global healthcare leader that specializes in innovative medicines. Her work at Novartis has allowed her to collaborate with leading scientists and researchers to push the boundaries of cancer treatment.
Collaborations
Throughout her career, Kristy has worked alongside notable colleagues such as Sunkyu Kim and Shivang Doshi. These collaborations have enabled her to leverage diverse expertise and enhance her research efforts, leading to the successful development of her patented therapies.
Conclusion
Kristy Haas’s contributions to cancer treatment through her innovative patents exemplify her commitment to improving healthcare. Her work at Novartis AG and collaborations with esteemed professionals underscore the importance of teamwork in the pursuit of groundbreaking discoveries in medicine. As she continues her research, Kristy stands at the forefront of innovation in oncology.